Satellite Symposium (VIII) – Gilead
Clinical Goal of CHB Treatment: Improving Survival and Quality of Life by Reducing the Risk of HCC
September 27, 2020（Sunday）12:15-13:35
Conference Room A, NTUH International Convention Center
Conference Room A, NTUH International Convention Center
* you can left or right swipe program.
| Time | Topic | Speaker | Moderator |
|---|---|---|---|
| Opening remarks |
Jia-Horng Kao
National Taiwan University Hospital
|
||
| When to treat: Reducing risk of HCC in patients infected with HBV |
Tung-Hung Su
National Taiwan University Hospital
|
Jia-Horng Kao
National Taiwan University Hospital
|
|
| How to treat: Multi-aspect consideration of oral anti-viral therapy to reduce HCC |
Ray Kim
Stanford University Medical Center, USA
|
Yi-Hsiang Huang
Taipei Veterans General Hospital
|
|
| Panel discussion and closing remarks |
Yi-Hsiang Huang
Taipei Veterans General Hospital
|
||
* you can left or right swipe program.